100 Albert Road
Level 4 South Melbourne
Melbourne, VIC 3205
Australia
61 3 9692 7222
https://medibio.com.au
Sector(s):
Industry:
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Thomas R. Young M.D. | Chief Exec. Officer | N/A | N/A | N/A |
Ms. Renee Stanton-Horne | Operations & Account Mang. | N/A | N/A | N/A |
Ms. Stephanie Ottens | Investor Relations Director | N/A | N/A | N/A |
Mr. Josh Purdy | PR Director | N/A | N/A | N/A |
Dr. Michael Player | Head of Research | N/A | N/A | N/A |
Dr. Matthew Flax | Head of Algorithm Devel. Team | N/A | N/A | N/A |
Mr. Archie Defillo M.D. | Chief Medical Officer | N/A | N/A | N/A |
Ms. Jennifer Solitario | Sr. VP of Corp. Health | N/A | N/A | N/A |
Mr. Massimiliano Grassi | Head of Artificial Intelligence | N/A | N/A | N/A |
Mr. Mathew Watkins C.A. | Company Sec. | N/A | N/A | N/A |
Medibio Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was incorporated in 1987 and is headquartered in Melbourne, Australia.
Medibio Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.